Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00892307 · ClinicalTrials.gov registry record

Adenosine Dual Source Computed Tomography (CT) Versus Adenosine Single Photon Emission Computed Tomography (SPECT)

A clinical trial of Coronary Artery Disease, sponsored by Cedars-Sinai Medical Center.

Completed
Registry status
34
Enrollment target
1
Study location

NCT00892307 is a study of Coronary Artery Disease that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 34 participants, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00892307, a study of Coronary Artery Disease, has completed, sponsored by Cedars-Sinai Medical Center.

COMPLETED
Registry status
34 participants
Enrollment target
1
Study location

Study Summary

Researchers hope that this new non-invasive multi-detector scanner (DSCT) will provide diagnostic information comparable to the combination of traditional SPECT (for function and blood flow) and CT imaging (for a precise anatomical view).

Conditions Studied

Coronary Artery Disease

Interventions

  • RADIATION Dual Source Multidetector CT (DSCT) w/ Adenosine enhancement

Study Locations (1)

California

  • Cedars-Sinai Medical Center - Los Angeles

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2007-02
Est. Completion 2011-05

Sponsor

Cedars-Sinai Medical Center

339 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00892307

The ClinicalTrials.gov registry entry for NCT00892307 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (97% lower). The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Dual Source Multidetector CT (DSCT) w/ Adenosine enhancement is the first listed.

NCT00892307 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00892307 about?

NCT00892307 is a clinical study titled "Adenosine Dual Source Computed Tomography (CT) Versus Adenosine Single Photon Emission Computed Tomography (SPECT)". Researchers hope that this new non-invasive multi-detector scanner (DSCT) will provide diagnostic information comparable to the combination of traditional SPECT (for function and blood flow) and CT imaging (for a precise anatomical view).

What is the current status of trial NCT00892307?

This trial is currently completed. The enrollment target is 34 participants. The study started on 2007-02. Estimated completion is 2011-05.

What conditions does trial NCT00892307 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

What interventions are being tested in trial NCT00892307?

The interventions under investigation include: Dual Source Multidetector CT (DSCT) w/ Adenosine enhancement (RADIATION).

Who is sponsoring clinical trial NCT00892307?

This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00892307 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Coronary Artery Disease

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.